Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Liccardo

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Physiology|October 18, 2013
Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapyAlessandro Cannavo, Daniela Liccardo, Walter J Koch
Hormone Research in Paediatrics|October 18, 2014
Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circleArianna Alterio, Anna Alisi, Daniela Liccardo, et al.
BMC Developmental Biology|February 3, 2021
Natriuretic peptides and Forkhead O transcription factors act in a cooperative manner to promote cardiomyocyte cell cycle re-entry in the postnatal mouse heartMir Ali, Daniela Liccardo, Tongtong Cao, et al.
Expert Review of Gastroenterology & Hepatology|September 28, 2013
Is there any link between dietary pattern and development of nonalcoholic fatty liver disease in adolescence? An expert reviewDaniela Liccardo, Anna Alisi, Gilda Porta, et al.
Journal of Clinical Medicine|July 27, 2022
Sex/Gender- and Age-Related Differences in β-Adrenergic Receptor Signaling in Cardiovascular DiseasesDaniela Liccardo, Beatrice Arosio, Graziamaria Corbi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 10, 2014
A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver diseaseKatharine Eng, Rocio Lopez, Daniela Liccardo, et al.
Expert Opinion on Pharmacotherapy|September 16, 2014
Current pharmacotherapy for treating pediatric nonalcoholic fatty liver diseaseClaudia Della Corte, Daniela Liccardo, Federica Ferrari, et al.
Vitamins and Hormones|January 26, 2019
Aldosterone and Myocardial PathologyAlessandro Cannavo, Andrea Elia, Daniela Liccardo, et al.
Heart Failure Clinics|May 14, 2019
β-Adrenergic Receptor Signaling and Heart Failure: From Bench to BedsideLeonardo Bencivenga, Daniela Liccardo, Carmen Napolitano, et al.
Plos One|August 15, 2014
The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver diseaseNaim Alkhouri, Sana Mansoor, Paola Giammaria, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Physiology|October 18, 2013
Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapyAlessandro Cannavo, Daniela Liccardo, Walter J Koch
Hormone Research in Paediatrics|October 18, 2014
Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circleArianna Alterio, Anna Alisi, Daniela Liccardo, et al.
BMC Developmental Biology|February 3, 2021
Natriuretic peptides and Forkhead O transcription factors act in a cooperative manner to promote cardiomyocyte cell cycle re-entry in the postnatal mouse heartMir Ali, Daniela Liccardo, Tongtong Cao, et al.
Expert Review of Gastroenterology & Hepatology|September 28, 2013
Is there any link between dietary pattern and development of nonalcoholic fatty liver disease in adolescence? An expert reviewDaniela Liccardo, Anna Alisi, Gilda Porta, et al.
Journal of Clinical Medicine|July 27, 2022
Sex/Gender- and Age-Related Differences in β-Adrenergic Receptor Signaling in Cardiovascular DiseasesDaniela Liccardo, Beatrice Arosio, Graziamaria Corbi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 10, 2014
A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver diseaseKatharine Eng, Rocio Lopez, Daniela Liccardo, et al.
Expert Opinion on Pharmacotherapy|September 16, 2014
Current pharmacotherapy for treating pediatric nonalcoholic fatty liver diseaseClaudia Della Corte, Daniela Liccardo, Federica Ferrari, et al.
Vitamins and Hormones|January 26, 2019
Aldosterone and Myocardial PathologyAlessandro Cannavo, Andrea Elia, Daniela Liccardo, et al.
Heart Failure Clinics|May 14, 2019
β-Adrenergic Receptor Signaling and Heart Failure: From Bench to BedsideLeonardo Bencivenga, Daniela Liccardo, Carmen Napolitano, et al.
Plos One|August 15, 2014
The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver diseaseNaim Alkhouri, Sana Mansoor, Paola Giammaria, et al.
Pageof 8